Expression of the extracellular domain of the human immunodeficiency virus type 1 envelope protein and its fusion with β-galactosidase in Saccharomyces cerevisiae

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 592-594

  Liu, Wei Feng ^a   Gao, Dong ^a   Wang, Zu Nong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE; HYBRID PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOGENICITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 0031877007     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.592-594.1998     Document Type: Article

References (22)

1. Barr, P. J., K. S. Steimer, E. A. Sabin, D. Parkes, C. George-Nascimento, J. C. Stephans, M. A. Wers, A. Gyenes, G. A. Van Nest, E. T. Miller, K. W. Higgins, and P. A. Luciw. 1987. Antigenicity and immunogenicity of domains of the human immunodeficiency virus (HIV) envelope polypeptide expressed in the yeast Saccharomyces cerevisiae. Vaccine 5:90-101.
2. Berman, P. W., L. Riddle, G. Nakamura, O. K. Haffar, W. M. Nunes, P. Skehel, G. Bryn, J. Groopman, T. Matthews, and T. Gregory. 1989. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160. J. Virol. 63:3489-3498.
3. Bolngnesi, D. 1990. Progress in vaccine developement against SIV and HIV. J. Acquired Immune Defic. Syndr. 3:390-394.
4. Chirmule, N., V. Kalyanaraman, N. Oyaizu, and S. Pahwa. 1988. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J. Acquired Immune Defic. Syndr. 1:425-430.
5. Dewer, R. L., V. Natarajan, M. B. Vasudevachari, and N. P. Salzman. 1989. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J. Virol. 63:129-136.
6. Di Marzo-Veronese, F., A. L. deVico, T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharam. 1985. Characterization of gp41 as the transmembrane protien coded by the HTLV-III/LAV envelope gene. Science 229:1402-1405.
7. Fisher, A. G., L. Ratner, H. Mitsuya, L. M. Marcelle, M. E. Harper, S. Broeder, R. C. Gallo, and F. Wong-Staal. 1986. Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233:655-659.
8. Freed, L. O., and M. A. Martin. 1995. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270: 23883-23886.
9. Gelderbloom, H. R., H. Reupke, and G. Pauli. 1985. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Lancet ii:1016-1017.
10. Ito. H., and K. Murate. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
11. Jones, E. W. 199O. Vacuolar proteases in yeast Saccharomyces cerevisiae Methods Enzymol. 185:372-386.
12. Kowaski, M., J. Potz, L. Basiripour, T. Dorman, W. C. Gou, S. Terwilliger, A. Daxton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
13. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp 160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
14. 4 molecule. Science 231:382-385.
15. Mittler, R. S., and M. K. Hoffman. 1989. Synergism between HIV gp 120 and gp120-specific antibody in blocking human T cell activation. Science 245: 1380-1382.
16. Muessing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Beuton, L. A. Lasky, and D. J. Capon. 1985. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 313:450-458.
17. Scorer, C. A., R. G. Buckholz, J. J. Clare, and M. A. Romanos. 1993 The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris. Gene 136:111-119.
18. Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3-20.
19. Smith, S., and S. Halling. 1984. Expression of canine parvovirus-β-galactosidase fusion proteins in Escherichia coli. Gene 29:263-269.
20. Ullmann, A. 1994. One-step purification of hybrid proteins which have β-galactosidase activity. Gene 29:27-31.
21. Wells, D. E., and R. W. Compans. 1990. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. Virology 176:575-586.
22. L promoter. Chin. J. Virol 6:111-116.